Author:
Grant Scott B.,Angelos Peter
Publisher
Springer International Publishing
Reference30 articles.
1. Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36:1080–6.
2. McIlvennan CK, Wordingham SE, Allen LA, et al. Deactivation of left ventricular assist devices: differing perspectives of cardiology and hospice/palliative medicine clinicians. J Card Fail. 2017;23:708–12.
3. Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 international society for heart lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157–87.
4. Centers for Medicare & Medicaid Services. Ventricular assist devices for bridge-to-transplant and destination therapy. Medicare learning Network (MLN) Matters 2014. Available at:
https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Netword-MLN/MLNMattersArticles/downloads/MM8803.pdf
.
5. The Joint Commission. Revised ventricular assist device destination therapy requirements. Jt Comm Perspect. 2013;33:6, 13.